These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34691026)

  • 1. Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis.
    Feng J; Fan S; Sun Y; Ren H; Guan H; Wang J
    Front Immunol; 2021; 12():717598. PubMed ID: 34691026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of B Cell Repertoire in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Feng J; Fan S; Sun Y; Zhang Z; Ren H; Li W; Cui L; Peng B; Ren X; Zhang W; Guan H; Wang J
    Front Immunol; 2020; 11():1539. PubMed ID: 32849520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography.
    Wegner F; Wilke F; Raab P; Tayeb SB; Boeck AL; Haense C; Trebst C; Voss E; Schrader C; Logemann F; Ahrens J; Leffler A; Rodriguez-Raecke R; Dengler R; Geworski L; Bengel FM; Berding G; Stangel M; Nabavi E
    BMC Neurol; 2014 Jun; 14():136. PubMed ID: 24950993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.
    Mizoguchi T; Hara M; Hirose S; Nakajima H
    Front Immunol; 2022; 13():845272. PubMed ID: 35242143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune synaptic encephalitis].
    Modvig S; Høi-Hansen CE; Uldall P; Somnier F
    Ugeskr Laeger; 2012 May; 174(21):1456-8. PubMed ID: 22640786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Workup and treatment of autoimmune encephalitis].
    Blaabjerg M; Mærsk-Møller CC; Kondziella D; Somnier F; Celicanin M; Andersen H; Bach FW; Pinborg LH
    Ugeskr Laeger; 2015 Nov; 177(45):V05150448. PubMed ID: 26573937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Epilepsy.
    Gaspard N
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-NMDA-receptor Encephalitis in an Adolescent With HIV Infection and Review of the Literature.
    Pinzon-Charry A; Wallace G; Clark JE; Nourse C
    Pediatr Infect Dis J; 2019 Aug; 38(8):e169-e171. PubMed ID: 31306397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
    Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
    Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune encephalitis-update: roles of autoantibodies in the pathogenesis].
    Tanaka K
    Rinsho Shinkeigaku; 2014; 54(12):1107-9. PubMed ID: 25672721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune encephalitis: recent updates and emerging challenges.
    Ramanathan S; Mohammad SS; Brilot F; Dale RC
    J Clin Neurosci; 2014 May; 21(5):722-30. PubMed ID: 24246947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased inflammatory cytokine production of antigen-specific CD4
    Dao LM; Machule ML; Bacher P; Hoffmann J; Ly LT; Wegner F; Scheffold A; Prüss H
    J Neurol; 2021 Jun; 268(6):2123-2131. PubMed ID: 33442772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
    Malter MP; Elger CE; Surges R
    Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Teratoma presenting as Anti NMDAR Antibody Negative Limbic Encephalitis.
    Thomas AG; Mohan M; Thomas R; Baby FM
    J Assoc Physicians India; 2019 Sep; 67(9):94-95. PubMed ID: 31561702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
    Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis.
    Dale RC; Pillai S; Brilot F
    Dev Med Child Neurol; 2013 Feb; 55(2):191-193. PubMed ID: 23151040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
    Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
    Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese Encephalitis Virus-Induced Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature.
    Tian M; Li J; Lei W; Shu X
    Neuropediatrics; 2019 Apr; 50(2):111-115. PubMed ID: 30620950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.